![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 14, 11246-11251, April 6, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Pharmacology and Physiology, University of
Rochester School of Medicine and Dentistry,
Rochester, New York 14642
In previous work (Sankaran, B., Osterhout, J.,
Wu, D., and Smrcka, A. V. (1998) J. Biol. Chem.
273, 7148-7154), we showed that overlapping peptides, N20K
(Asn564-Lys583) and E20K
(Glu574-Lys593), from the catalytic domain of
phospholipase C (PLC)
Characterization of a Phospholipase C
2-Binding Site Near the
Amino-terminal Coiled-coil of G Protein 
Subunits*
2 block G
-dependent
activation of PLC
2. The peptides could also be directly
cross-linked to 
subunits with a heterobifunctional cross-linker
succinimidyl
4-[N-maleimidomethyl]-cyclohexane-1-carboxylate. Cross-linking of peptides to G
1 was inhibited by PLC
2 but not by
i1(GDP), indicating that the
peptide-binding site on
1 represents a binding site for
PLC
2 that does not overlap with the
i1-binding site.
Here we identify the site of peptide cross-linking and thereby define a
site for PLC
2 interaction with
subunits. Each of the 14 cysteine residues in
1 were altered to alanine. The
ability of the PLC
2-derived peptide to cross-link to each 
mutant was then analyzed to identify the reactive sulfhydryl moiety on the
subunit required for the cross-linking reaction. We find that
C25A was the only mutation that significantly affected peptide cross-linking. This indicates that the peptide is specifically binding
to a region near cysteine 25 of
1 which is located in the amino-terminal coiled-coil region of
1 and
identifies a PLC-binding site distinct from the
subunit interaction site.
*
This work was supported by Grant GM 53536 from the National
Institutes of Health.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Pharmacology
and Physiology, University of Rochester School of Medicine and
Dentistry, 601 Elmwood Ave., Rochester, NY 14642. Tel.: 716-275-0892; Fax: 716-273-2652; E-mail: Alan_Smrcka@URMC.rochester.edu.
This article has been cited by other articles:
![]() |
C. Yuan, M. Sato, S. M. Lanier, and A. V. Smrcka Signaling by a Non-dissociated Complex of G Protein beta{gamma} and {alpha} Subunits Stimulated by a Receptor-independent Activator of G Protein Signaling, AGS8 J. Biol. Chem., July 6, 2007; 282(27): 19938 - 19947. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sato, M. J. Cismowski, E. Toyota, A. V. Smrcka, P. A. Lucchesi, W. M. Chilian, and S. M. Lanier Identification of a receptor-independent activator of G protein signaling (AGS8) in ischemic heart and its interaction with Gbeta{gamma} PNAS, January 17, 2006; 103(3): 797 - 802. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chen, F. Lin, and H. E. Hamm RACK1 Binds to a Signal Transfer Region of G{beta}{gamma} and Inhibits Phospholipase C {beta}2 Activation J. Biol. Chem., September 30, 2005; 280(39): 33445 - 33452. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Bonacci, M. Ghosh, S. Malik, and A. V. Smrcka Regulatory Interactions between the Amino Terminus of G-protein {beta}{gamma} Subunits and the Catalytic Domain of Phospholipase C{beta}2 J. Biol. Chem., March 18, 2005; 280(11): 10174 - 10181. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Goubaeva, M. Ghosh, S. Malik, J. Yang, P. M. Hinkle, K. K. Griendling, R. R. Neubig, and A. V. Smrcka Stimulation of Cellular Signaling and G Protein Subunit Dissociation by G Protein {beta}{gamma} Subunit-binding Peptides J. Biol. Chem., May 23, 2003; 278(22): 19634 - 19641. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |